SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 214 filers reported holding SAGE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $452,000 | -2.4% | 14 | 0.0% | 0.00% | – |
Q1 2022 | $463,000 | -22.3% | 14 | 0.0% | 0.00% | – |
Q4 2021 | $596,000 | -3.9% | 14 | 0.0% | 0.00% | – |
Q3 2021 | $620,000 | -97.0% | 14 | -96.4% | 0.00% | -100.0% |
Q2 2021 | $20,459,000 | -29.9% | 390 | 0.0% | 0.01% | -37.5% |
Q1 2021 | $29,190,000 | -13.5% | 390 | 0.0% | 0.01% | -20.0% |
Q4 2020 | $33,737,000 | +9092.6% | 390 | +6400.0% | 0.01% | – |
Q3 2020 | $367,000 | +47.4% | 6 | 0.0% | 0.00% | – |
Q2 2020 | $249,000 | +44.8% | 6 | 0.0% | 0.00% | – |
Q1 2020 | $172,000 | -61.7% | 6 | 0.0% | 0.00% | – |
Q4 2019 | $449,000 | -46.7% | 6 | 0.0% | 0.00% | – |
Q3 2019 | $842,000 | -23.3% | 6 | 0.0% | 0.00% | – |
Q2 2019 | $1,098,000 | +15.1% | 6 | 0.0% | 0.00% | – |
Q1 2019 | $954,000 | +65.9% | 6 | 0.0% | 0.00% | – |
Q4 2018 | $575,000 | -31.1% | 6 | 0.0% | 0.00% | – |
Q3 2018 | $834,000 | -99.2% | 6 | -99.1% | 0.00% | -100.0% |
Q2 2018 | $103,215,000 | -0.1% | 662 | 0.0% | 0.02% | -19.0% |
Q1 2018 | $103,305,000 | – | 662 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RTW INVESTMENTS, LP | 5,149,482 | $105,976,340 | 2.24% |
Palo Alto Investors LP | 1,005,776 | $20,698,870 | 1.96% |
Boxer Capital, LLC | 1,094,000 | $22,514,520 | 1.20% |
Bellevue Group AG | 3,513,351 | $72,304,764 | 1.16% |
PDT Partners, LLC | 181,625 | $3,737,843 | 0.47% |
EASTERLY INVESTMENT PARTNERS LLC | 195,643 | $4,026,333 | 0.44% |
Harvest Investment Services, LLC | 30,302 | $623,615 | 0.40% |
Simplify Asset Management Inc. | 120,030 | $2,470,217 | 0.28% |
SAMLYN CAPITAL, LLC | 739,867 | $15,226,463 | 0.25% |
CAXTON ASSOCIATES LP | 68,035 | $1,400,160 | 0.19% |